Rinucumab

Tax included
Rinucumab (REGN 2176), a monoclonal antibody, is a PDGF inhibitor. Rinucumab (REGN 2176) could be used for the study of neovascular age-related macular degeneration.
MedChemExpress 
HY-P99402

Data sheet

Size
Multiple sizes
Reactivity
PDGFR
Application
Metabolism-protein/nucleotide metabolism
CAS
1569263-06-4